Encinitas, California--(Newsfile Corp. - February 11, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback